You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

AbstractFullPdf
Dec 2020330330125
Jan 2021431431129
Feb 202110710740
Mar 202114714739
Apr 2021858531
May 2021989828
Jun 202110210238
Jul 2021757531
Aug 2021727227
Sep 2021646437
Oct 2021686847
Nov 2021515145
Dec 2021454622
Jan 2022515224
Feb 202233349
Mar 2022666626
Apr 2022566236
May 2022617040
Jun 2022505217
Jul 2022273020
Aug 2022394314
Sep 2022313354
Oct 2022384122
Nov 2022303010
Dec 202228289
Jan 202319197
Feb 2023666922
Mar 2023282924
Apr 202331315
May 2023293110
Jun 2023272710
Jul 2023262610
Aug 2023272713
Sep 202317176
Oct 2023272710
Nov 2023202010
Dec 2023292910
Jan 2024192011
Feb 2024303019
Mar 2024303046
Total261026491133